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random walks, coupled with a Michaelis-Menten type mechanism which views the endothelial vascular
endothelial cell growth factor (VEGF) receptors as the catalyst for transforming into a proteolytic enzyme in
order to model the first stage. It is the purpose of this paper to present a more descriptive yet not overly
complicated mathematical model of the biochemical events that are initiated when VEGF interacts with
endothelial cells and which result in the cell synthesis of proteolytic enzyme. We also delineate via chemical
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A MATHEMATICAL MODEL FOR THE ROLE OF CELL SIGNAL TRANSDUCTION
IN THE INITIATION AND INHIBITION OF ANGIOGENESIS
HOWARD A. LEVINE & ANNA L. TUCKER & MARIT NILSEN-HAMILTON
Abstract. Neovascular formation can be divided into three main stages (which may be overlapping): (1)
changes within the existing vessel, (2) formation of a new channel, (3) maturation of the new vessel.
In a series of three papers, [14, 12, 15] the authors introduced a new approach to angiogenesis, based on
the theory of reinforced random walks, coupled with a Michaelis-Menten type mechanism which views the
endothelial VEGF (vascular endothelial cell growth factor) receptors as the catalyst for transforming into a
proteolytic enzyme in order to model the first stage.
It is the purpose of this paper to present a more descriptive yet not overly complicated mathematical
model of the biochemical events that are initiated when VEGF interacts with endothelial cells and which
result in the cell synthesis of proteolytic enzyme. We also delineate via chemical kinetics, three mechanisms
by which one may inhibit angiogenesis (inhibition of growth factor, growth factor receptor and protease
function).
1. Introduction
The cell, as the smallest denominator of living organisms capable of independent life, takes in and metabo-
lizes nutrients that are used for its maintenance, movement and reproduction. In the context of a multicellular
organism, cells must also use nutrients to synthesize signals that are released and that regulate the activities
of other cells. An extraordinary number of metabolic pathways,signal transduction cascades and other regu-
latory elements are required for a cell to synthesize the macromolecules necessary for life and to coordinate
its own activities. One has only to confront a diagram such as can be found on page 415 of [28] to obtain a
sense of the complexity of cellular metabolism.
Many more synthetic and regulatory mechanisms are involved in maintaining the tightly coordinated and
cooperating multicellular entity that we refer as the body. Deviation in this cellular community of the body
from the normal tightly organized and cooperating mode can result in one of the many forms of degeneration
known as disease.
In tumor angiogenesis also, there are several pathways by which an avascular tumor may induce the
endothelial cell lining of a nearby capillary to break through the capillary lamina and grow toward the
tumor. See [6] and the review article [34] for example. Two excellent review articles which will provide the
reader with an introduction to tumor angiogenesis are to be found in [18, 19].
It is the purpose of this article to study one of the pathways by which growth factor is “converted” into
protease, namely the MAP kinase pathway, and to present a somewhat more detailed kinetic mechanism
for the “conversion” of growth factor into protease by endothelial cells than the simplified mechanism that
was utilized in [14, 12, 15]. The mechanism on which we focus is illustrated in Figure 2 of [3] and which
may be viewed at www.hosppract.com/issues/1999/01/eckhardt.htm. A single molecule of VEGF binds to
a cell surface receptor and initiates a cascade of events within the cell cytoplasm and the cell nucleus which
results in the production of several molecules of proteolytic enzyme as well as in a receptor of the same type
that was bound to the growth factor in the first place. Two excellent articles that discuss the MAP-kinase
pathway that we discuss here are [9, 24].
Date: July 10, 2002.
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The MAP kinases constitute an important signaling cascade that regulates transcriptional and metabolic
activity. This group of protein kinases is organized as a multi-protein complex associated with one or more
scaffold proteins. Activation of the first kinase, Raf, is achieved by the monomeric G-protein Ras, which is in
turn activated by growth factor receptors that are bound to their respective growth factor ligands. Activated
Raf phosphorylates and activates ERK (MAP kinase-kinase) which then phosphorylates and activates MAP
kinase. MAP kinase phosphorylates and activates transcription factors such as AP-1 that interacts with
DNA and stimulates specific gene expression.
The full mechanism (or at least a substantial part of it that is already understood) is outlined in the
appendix to this paper. The reader will see that the kinetics discussed there lead to a system of at least
thirty ordinary differential equations that describe the chemical kinetics of this pathway. Several difficulties
arise with the use of such a system of ordinary differential equations to replace the simple model used in
[14, 12, 15]. First, the size of the system itself is formidable. Secondly, and more importantly, the kinetic
constants involved at most steps are unknown.
There are a number of papers that study the kinetics of various pieces of this pathway and how they
influence cell signaling. For example, in [11], the authors focus their attention on how the scaffold proteins
affect protein kinase signaling.
2. The Proposed Mechanism
In [14, 12, 15], we presented a simplified model for the interaction of angiogenic growth factors such as
VEGF with growth factor receptors on the surface of endothelial cells as follows:
If V denotes a molecule of angiogenic factor (substrate) and R denotes some receptor on the endothelial
cell wall, they combine to produce an intermediate complex, RV which is an activated state of the receptor
that results in the production and secretion of proteolytic enzyme, C, and a modified intermediate receptor
R′. The receptor R′ is subsequently removed from the cell surface after which it is either recycled to form
R or a new R is then synthesized by the cell. It then moves to the cell surface.
Likewise, the proteolytic enzyme molecule, C, moves to the exterior of the cell surface where it degrades
the laminar basement membrane leaving products F ′ by acting as a catalyst for fibronectin degradation.
The products F ′ need not concern us here. We used classical Michaelis-Menten kinetics for this standard
catalytic reaction.
The point of view there was that the receptors at the surface of the cell function the same way an enzyme
functions in classical enzymatic catalysis. In symbols,
V +R
k1

k(−1)
RV,
RV
k2−→ C +R′,
R′
k′2−→ R,
C + F `1−→ CF,
CF
`2−→ F ′ + C.
(2.1)
The mechanism was simplified by combining steps (2) and (3) in the above mechanism as follows:
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V +R
k1

k(−1)
RV,
RV
k2−→ C +R,
C + F `1−→ CF,
CF
`2−→ F ′ + C.
(2.2)
The principle problem with this mechanism is that it does not reflect the fact that a single molecule of
growth factor signals a cascade of intracellular events that result in a cellular response that results in several
(perhaps hundreds) of molecules of protease.1 One might be tempted to replace (2.2) by
V +R
k1

k(−1)
RV,
RV
k2−→ nC +R,
C + F `1−→ CF,
CF
`2−→ F ′ + C.
(2.3)
where n is the number of protease molecules produced in response to a single molecule of growth factor.
(This would lead to the production-consumption equations for protease and growth factor of the form:
d[C]
dt
= nk2[RV ] = −nd[V ]
dt
.(2.4)
where [Z] denotes the concentration of species Z in micro-moles per liter (micromolarity).)
However, such a mechanism is not stoichiometric. On the other hand, the more detailed mechanism
outlined in the appendix suffers from the drawbacks mentioned above.
In order to have a relatively simple mechanism that is stoichiometric, we need to introduce into the model
a source of supply of amino acids from which the ribosome can direct the assembly into protease and into
cell receptors using the respective mRNA’s as templates. These amino acids come from the blood plasma
that bathes the endothelial cells on their lumenal side or through the basement membrane and from the
surrounding tissue on their ablumenal side via the cell surface transport proteins or directly from those
already found in the cytoplasm.
To describe the mechanism symbolically, we use the notation in Table 1:
With these definitions in mind we write:
X + Pt
k1

k(−1)
XPt,(2.5)
XPt
k2

k(−2)
Y + Pt
1An additional complicating factor is that this mechanism, like most kinetic mechanisms, does not take into account the local
environment. Here the complicating issue is the fact that the number n may depend upon the concentration of growth factor at
the cell surface. For example, it was observed that the concentration of protease is a bimodal function of the concentration of
growth factor say [C] = φ([V ]) ([27]). For the simulations we present here, we shall assume very low concentrations of growth
factor are present. Then the number n = φ′(0) and can be numerically interpolated from the data in [27] for example. However,
this approximation cannot be employed near the tip of a growing capillary as it marches toward a source of high concentration
of growth factor.
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which describes the transport of amino acids to and from the exterior of the cell through the lipid bilayer and
into the cell cytoplasm.2(The technical term for this is “facilitated diffusion”.) Next, growth factor interacts
with the EC cell receptor
V +R
k3

k(−3)
RV,
RV
k4−→ V ∗ + Rˆ
(2.7)
which roughly describes the invagination of the RV complex with the resultant cellular destruction of growth
factor and the production of a G−protein activated intermediate, Rˆ. Next, Rˆ initiates events that result in
the assembly of intracellular amino acids into intracellular protease which is then converted to extracellular
protease.
Rˆ+ Y
k5(t)−−−→ nC ′ +R,
C ′
k5(t)
′
−−−→ C.
We combine these two steps in a single equation:
Rˆ+ Y
k5(t)−−−→nC +R.(2.8)
It is important to note that all of the k′s in the above mechanism are constant save k5. We take k5 to be
time dependent and of the following form:
k5(t) = κH(t− t0)(2.9)
where H(x) denotes the Heaviside function
H(x) =
{
1, if x ≥ 0,
0, if x < 0
and where t0 is the mean time of the endothelial cell protease response to growth factor. It can be estimated
that the EC begin the production of protease approximately 15 − 20 hours after the growth factor ligand
2The mechanism (2.5) can be viewed as a shortened version of a mechanism for the two way flux of cationic amino acids
across a plasma membrane discussed in [31, 32]. In the first of these references the authors “report that the inward and
outward transport of cationic amino acids through the plasma membrane of fibroblasts and HTC cells is mediated mostly by a
single saturable transport system · · · ”. They also report that “The mediated arginine influx is half maximally saturated at an
external substrate concentration of 0.1 to 0.2 as high as the apparent intra cellular concentration that half maximally saturates
the eﬄux.” This leads us to an estimate for Ke = k1k2/k(−1)k(−2) ≈ 15.0 for the value of the equilibrium constant when (2.5)
is in equilibrium. The mechanism used in [31, 32] which describes the iso-uni-uni transport system across the cell membrane
has the form:
X + P 1t
k1
k(−1)
Z,
P 1t
k(−3)

k3
P 2t ,(2.6)
Z
k2
k(−2)
Y + P 2t .
(See [21] for a very thorough treatment of the whole issue of enzyme kinetics in addition to the present mechanism.) Here
Z = XP 1t = Y P
2
t represents the intermediate while the second equation represents the exchange of extracellularly oriented
transport protein P 1t with intracellularly oriented proteinP
2
t . (Notice that in the first and third of these reactions, the arrows
pointing from the extra-cellular to the intracellular side of the membrane have rate constants with positive subscripts, while
those pointing in the other direction have negative subscripts. In the second, the convention is reversed.) When (2.6) is in
equilibrium, the equilibrium constant is Ke = k1k2k3/k(−1)k(−2)k(−3) = [Y ]/[X]. Mechanism (2.5) is is a condensed version
of (2.6). When the forward and reverse rate constants in the second step of (2.6) are the same, this expression for Ke reduces
to ours.
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binds with the cell receptor. In the Appendix below we have attempted to list some of the mechanistic steps
responsible for this delay.3
Finally this protease degrades the proteins of the basement lamina and the extracellular matrix:
C + F
`1

`(−1)
CF,
CF
`2−→ F ′ + C.
(2.10)
where the total available protease is given by
[C]total = [C] + [CF ] = [C]0.
If the total protease were constant, then we could write (in the absence other sources of basement lamina
proteases),
d[F ]
dt
= −Kcat[C]0[F ]
Km + [F ]
in the region where the Michaelis-Menten kinetics applies. However, in our case, [C]0 is not fixed. We will
replace it by the total concentration of protease that results from step (2.10) as a function of time. We have
carried out a careful justification for this in [23]. (Kcat = `2 and Km = (`(−1) + `2)/`1.)
The variables in Table 1 that are of interest to us are v, c, r, rˆ, f. In addition we will need notationthe
endothelial cell density. This we introduce later.
A set of chemical equations such as (2.5)-(2.8) generally does not take into account other influences
on species concentrations, such as crowding or dispersion. For example, the transport proteins and other
components of an endothelial cell will become more concentrated in three-dimensional space as the local cell
density increases. To account for this geometric effect, we will include a term C ′r(t) in the rate equation
for the transport cell density. This is the number of additional micromoles per liter per unit time by which
the concentration of transport protein is increased due to crowding or dispersion ([23]). We assume that
Cr(0) = 0.
3The use of generic intermediates such as Y and the introduction of “delays” such as we have done above is not uncommon
in modeling biochemical kinetics. In particular, in [10], the authors have presented a kinetic model for the p53−Mdm2 feedback
loop which employs both of these devices.
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The Law of Mass Action applied to the chemical equations (2.5)-(2.8) yields4:
∂s
∂t
= −k1s(t)p(t) + k(−1)`(t),
∂p
∂t
= −k(−2)y(t)p(t)− k1s(t)p(t) + (k(−1) + k2)`(t) + C ′r(t),
∂`
∂t
= k1s(t)p(t) + k(−2)y(t)p(t)− (k(−1) + k2)`(t),
∂m
∂t
= k3r(t)v(t)− (k(−3) + k4)m(t),
∂y
∂t
= k2`(t)− k5(t)rˆ(t)y(t)− k(−2)y(t)p(t),
∂v
∂t
= k(−3)m(t)− k3r(t)v(t),
∂r
∂t
= k5(t)rˆ(t)y(t) + k(−3)m(t)− k3r(t)v(t),
∂rˆ
∂t
= k4m(t)− k5(t)rˆ(t)y(t),
∂c
∂t
= nk5(t)rˆ(t)y(t)− µc(t)
(2.11)
(The quantities of amino acids resulting from growth factor degradation are assumed to be negligible in
comparison to the quantities of amino acids from the surrounding tissue and blood plasma needed to assemble
protease. Thus the rate equation for this quantity is omitted from the above list.)
In the last of the equations above we have included the term −µc which includes the effect of protease
decay. The half life, ln 2/µ, is fairly small.
Suppose the initial value of growth factor is v0 = 0. Then the above mechanism will not induce any
protease. In this case, we may assume that the mechanism of protein transport, (2.5) is in equilibrium and
the concentrations of X,Y, P, L are all constants. Calling them s0, y0, p0, `0 we have
y0 =
k1k2s0
k(−1)k(−2)
= Kes0,
`0 =
(k1s0 + k(−2)y0)p0
k(−1) + k2
=
k1s0p0
k(−1)
.
(2.12)
Representative values of the rate constants and ptotal = p0 + `0, s0 may be found from the literature. Some
of them are given in our simulations below.
In all cases, when c(0) = 0 we have the following conservation laws where r0 is the number of available
growth factor receptors:
s(t) + y(t) = s0 + y0 − 1
n
(
c(t) + µ
∫ t
0
c(t′) dt′
)
,
p(t) + `(t) = p0 + `0 + Cr(t),
rˆ(t) + r(t) +m(t) = rˆ0 + r0 +m0,
rˆ(t) + v(t) +m(t) = rˆ0 + v0 +m0 − 1
n
(
c(t) + µ
∫ t
0
c(t′) dt′
)(2.13)
4Partial time derivatives are used here in anticipation of the material in the sequel in which the concentrations will also
exhibit dependence on spatial variables.
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where m0, rˆ0 are constants of integration.5
Our analysis will be simplified considerably if we assume that the concentrations of the intermediates XPt
and RV are nearly constant, i. e. that X is in excess and either R is excess relative to V or vice versa, so
that
`(t) =
s(t)p(t)
K1m
+
y(t)p(t)
K
(−2)
m
,
m(t) =
r(t)v(t)
K2m
,
(2.14)
where we have set K1m = (k(−1) + k2)/k1, K
(−2)
m = (k(−1) + k2)/k(−2), and K2m = (k4 + k(−3))/k3. (We are
assuming reaction (2.5) involving transport proteins is of Michaelis-Menten type in that the concentration
of the intermediate does not vary much in time. We also assume that (2.7) enjoys a similar property in so
far as the first equation in that pair is concerned. This involves the assumption that the growth factor is
present in very low concentrations relative to the number of available receptors.) (Notice that (2.14) forces
the choice
m0 =
r0v0
K2m
(2.15)
upon us.)
Some routine algebra leads to the following system of algebraic and differential equations:
y − y0 = (s0 − s)− 1
n
(
c(t) + µ
∫ t
0
c(t′) dt′
)
,
z(t) =
s(t)
K1m
+
y(t)
K
(−2)
m
,
r = r0 + v − v0 + 1
n
(
c(t) + µ
∫ t
0
c(t′) dt′
)
,
rˆ =
r0 + v +K2m
K2m
(v0 − v)− K
2
m + v
K2m
[
1
n
(
c(t) + µ
∫ t
0
c(t′) dt′
)]
,
∂s
∂t
=
(
−k2s(t)
K1m
+
k(−1)y(t)
K
(−2)
m
)(
p0 + `0 + Cr(t)
1 + z(t)
)
,
∂v
∂t
= − k4
K2m
vr,
∂c
∂t
= nk5(t)rˆy − µc.
(2.16)
5In the case that n depends upon the local concentration of of v, n = n(v) say, then the quantity
1
n
(
c(t) + µ
∫ t
0
c(t′) dt′
)
must be replaced by the expression [
c(t)
n(v(t))
+
∫ t
0
(
µc(t′)
n(v(t′))
+
n′(v(t′))vt(t′)c(t′)
n2(v(t′))
′)
dt′
]
in (2.13) and every equation containing the former expression which follows from this. That n depends on v can be seen
experimentally from [27, 30]. From the point of view of an individual cell, one cannot assert that n(v) molecules of protease will
be produced for a single molecule of growth factor. However, the reader should understand, that we are dealing with ensemble
averages here, as is the case in all cases involving chemical kinetics. That is, we are not dealing with individual cells but with
cell densities and viewing cells in the same spirit as one views electrons, i.e. as a probability density.
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where we have suppressed the time variable. We also take
rˆ0 = 0.(2.17)
This is just the statement that, initially, there are no G-protein activated receptors.
Next we imagine endothelial cells distributed along a capillary of length L in some nonuniform manner.
We view this distribution as one of cell density rather than as individual cell number. The point of view
here is the same as in quantum mechanics. We are not looking at individual cells but rather as a probability
density. Therefore the endothelial cell density (as well as the other quantities in Table 1) depend on position
as well as time. Thus, [V ](t) = v(x, t) etc. just as was done in [14, 12].
We now have six dependent variables s, y, c, v, r, rˆ along with three differential equations and three alge-
braic equations in (2.16).
However, we want to model the impact of these variables on cell movement and tissue degradation, i. e.
on η, f where η is the cell density and f is the density of the capillary wall proteins (loosely called fibronectin
here).
Thus two problems remain. First, we must relate the crowding of the transport proteins to the endothelial
cell density and second, we need two more equations that relate η, f to s, y, c, v, r, rˆ.
The first task is relatively easy. We write p0total = p0 + `0 = δ0η0 where p
0
total is the total available number
of transport proteins per cell. δ0 is the density (in micro-moles per liter) of transport proteins on the surface
of endothelial cells in a normal capillary. We then write p0 + `0 + Cr(x, t) = δ(x, t)η(x, t) ≈ δ0η(x, t).
The second task is more complex. We need the rate equation for the protein (loosely designated as
fibronectin) density of the basement lamina. This is a complex structure made up primarily of fibronectin
and various other collagens. The differential equation we used in [14, 12, 15] that describes the time evolution
of this protein density is:
∂f
∂t
=
4f
Tf
(
1− f
fM
)
η
η0
− Kcatcf
Km + f
(2.18)
where now Kcat = `2 and Km = (`(−1) + `2)/`1 are the kinetic constants arising from the second pair of
kinetic equations in (2.3). fM is the density of the BL and Tf is the logistic growth time.6
The second missing equation is a differential equation that describes the time evolution of η. This is a
somewhat involved story.
3. Reinforced Random Walk
It is expected that endothelial cells will move into cavities in the extracellular matrix created by the
protease they express in response to the VEGF stimulus. The point of view we adopt here is the same as
was used in [14, 12, 15] and is in marked contrast to earlier works. In [15] the relevant literature was cited
and the differences in approach were spelled out in some detail.
The underlying assumptions (justified in detail in [14, 12, 15]) are the following:
1. The movement of endothelial cells in tissues is not random but depends upon the local environment in
which each cell finds itself.
2. The movement of EC in response to growth factor is indirect. Endothelial cells will move up a protease
gradient (chemotactic movement) in response to the protease they generate when stimulated by VEGF.
This chemotactic movement is also chemokinetic, i. e. it depends upon the concentration of protease
as well as its gradient. More precisely, if the concentration of protease is small, but not too small,
the cells will move up the protease gradient. However, if the protease concentration is too large, the
protease will destroy the cells [20]. We can interpret this as saying that the cells will avoid regions
6In Tf ≈ 18 hours, fM moles of fibronectin will be generated by η0 endothelial cells, [33]. In the absence of protease, η = η0
where η0 is the background concentration of EC in a normal capillary. We assume a logistic growth of fibronectin in this case,
i. e. that ft = βf(1− f/fM ) for some β. Therefore fM = β
∫ T
0 f(t)(1− f(t)/fM ) dt ≤ fMβTf/4. The inequality will be sharp
when β = 4/Tf .
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where the protease gradient is too large or by saying that they will move down the protease gradient
in such cases.
3. Endothelial cells will move down a fibronectin gradient (haptotactic movement) when the fibronectin
density is high and up the fibronectin gradient when the fibronectin density is small.
The cell movement equation takes the form:
∂η
∂t
= D
∂
∂x
(
η
∂
∂x
(
ln
η
τ(c, f)
))
(3.1)
which may be written in the more standard form:
ηt = Dηxx −D
(
η
τccx + τffx
τ(c, f)
)
x
= Dηxx −D(η(ln τ)x)x.(3.2)
The function τ(c, f) is called the probability transition rate function. The ratios ∂cτ(c, f)/τ(c, f) and
∂fτ(c, f)/τ(c, f) are known as the chemotactic sensitivity coefficients for protease and for fibronectin respec-
tively.
The equation (3.1) is sometimes called the continuous form of the master equation. We shall call it the
master equation. In [17] such an equation was used as a model for the study of fruiting bodies such as
Myxococcus fulvus and Dictyostelium discoideum amoeba. There τ was a function of the local concentration
cyclic adenosine monophosphate, a compound excreted by these amoeba as they consume their local food
supply. It has been observed that these cells aggregate as their food supply is consumed, i. e., as the local
concentration of cAMP increases.7 The idea of reinforced (or biased) random walk seems to have its origins
in [2].
The chemotactic sensitivity functions are phenomenological in character. For example, if the cell motion
were completely random, we take τ(c, f) = constant. The above equations then reduce to the one dimensional
diffusion equation and the cell density will become uniform in x with time. If the movements depended
solely upon the gradients of c, f , a natural choice might be τ(c, f) = const exp(ac) exp(−bf) where a, b are
positive constants. The sensitivities vanish when τ(c, f) is constant whereas, in this case, the sensitivities are
uniformly positively correlated (a > 0) with protease and uniformly negatively correlated with fibronectin
(−b < 0).8
The dynamical equation (3.1) then suggests that if c, f tend to steady state functions c∞(x), f∞(x), the
limiting form of the cell density should be
lim
t→+∞ η(x, t) = Ae
(ac∞(x)−bf∞(x))
where A is some constant of proportionality.
7In [13], some of the mathematical properties of the solutions of the problem obtained numerically in [17] were elucidated.
8The phrase “η is positively correlated with c” is defined as follows. Consider the first order partial differential equation
Ut + [τ ′(v)vx/τ(v)]Ux = 0 where U, v are functions of (x, t). (In the present context think of U = η and v = c and τ ′(v)/τ(v)
as the chemotactic sensitivity.) We say U is positively correlated with v at a point (x, t) if the characteristic of the pde
Ut + [τ ′(v)vx/τ(v)]Ux = 0 at (x, t) has positive slope if vx(x, t) is positive and the characteristic has negative slope if vx(x, t)
is negative. The correlation will be positive if the sensitivity τ ′(v)/τ(v) is positive, negative if the sensitivity is negative, and
neutral if the sensitivity vanishes.
When the sensitivity coefficient is constant, we say the correlation is uniform.
The geometric meaning is that when U is positively correlated with v, then “U will transported to the right when v is
increasing and to the left when v is decreasing.” Thus if v depends only upon x and has a single positive maximum, U will
tend to aggregate at the point where the maximum occurs. Similarly, if U is negatively correlated with v, then and v has a
minimum, U will aggregate at the point where the minimum occurs.
An interesting situation arises when the sensitivity changes sign. For example, suppose τ ′(v)/τ(v) = 1 − v and v(x) =
1 + (2/pi)tan−1x so that x = 0 is an inflection point for v. Then (1 − v)vx is positive for x < 0 and negative for x > 0.
Therefore U will be positively correlated with v for x < 0 and negatively correlated with v for x > 0. Thus U will aggregate at
the inflection point of v, namely x = 0.
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When the movement is chemokinetic as well as chemotactic, the sensitivity factors will depend on c, f .
It seems reasonable to assume that cell movement will be very sensitive to small concentrations of protease
and will be positively correlated with the enzyme. It is known that in the presence of large concentrations
of protease, the cells will be degraded and hence their movement cease.
Likewise, it is reasonable to assume that cell movement will be sensitive to low, but not too low, fibronectin
densities and insensitive to large fibronectin densities. (If the fibronectin density is too low, the cell pseudo-
podia have nothing to which to attach themselves so that they can pull the cell along. On the other hand,
if the fibronectin density is too high in a region, then the cells cannot invade that region. This has been
documented in the literature [26].)
This suggests that we should take τ(c, f) = τ1(c)τ2(f) since these movements should be independent.
We could take the protease sensitivity to be of the form:
τ ′1(c)
τ1(c)
=
γ1
α1 + c
,
so that for the protease probability transition rate function factor,
τ1(c) = A(α1 + c)γ1
where α1 is a small positive constant. However, we really do not expect the probability rate to become
infinite as c ranges over all positive numbers. This suggests that we take τ1 as we did in [14, 12, 15] namely:
τ1(c) = A(α1 + c)
γ
1(α2 + c)
−γ1 .
However, this does not convey the full thrust of item 2 above.
A more systematic way to proceed is to consider the biology more closely. A protease sensitivity function
should have compact support contained in some interval [0, c0) vanish at the ends of this interval, and have
a unique positive maximum at some point cmax.
Then, not only will the sensitivity change sign near the maximum of this function, the cells will tend to
aggregate near the maximum value of this function and de-aggregate near the ends of the interval. That is,
η will be positively correlated with c for c < cmax and negatively correlated with c for c > cmax. As the value
of c approaches the end values, 0, c0, the contribution of protease to cell movement will become negligible if
the sensitivity vanishes near the end points .9
Because simulations will involve computation of τ ′1(c)/τ1(c), we relax the condition that τ1 vanish at the
end points. We take ϕ(c) to be a function of the form described above. Then
τ1(c) = [a+ ϕ(c)]γ(3.3)
where a, γ are positive constants chosen such that aγ is very small. Then the chemotactic sensitivity function
becomes:
τ ′1(c)
τ1(c)
=
γϕ′(c)
a+ ϕ(c)
(3.4)
The choice for f is similar. Specifically, we take If we take ψ(f) to be a function of the form described
above, then
τ2(f) = [a′ + ϕ(f)]γ
′
(3.5)
where a′, γ′ are positive constants chosen such that a′γ′ is very small. Then the haptotacic sensitivity
function becomes:
τ ′2(f)
τ2(f)
=
γ′ψ′(f)
a+ ψ(f)
(3.6)
9The requirement that τ1 have compact support can be relaxed. For example, we might consider τ1(c) = Acm exp(−acn)
rather than τ1(c) = Acm(c0 − c)n. The positive constants in both forms must be determined empirically.
CELL SIGNALING AND GROWTH FACTORS 11
Beyond this, the functional forms of φ, ψ must be determined experimentally although we may always
normalize them so that they take values in [0, 1]. The larger the constant γ (resp. γ′) is, the more concentrated
about the value cmax (resp. fmax) the EC density will be.
The specific choices we take are given in the section on simulations.
Remark 1. This is a somewhat different philosophical approach than we took in [14, 12, 15]. However, we
believe that this approach more accurately reflects the underlying biology.
.
4. The System in One Dimension
The system of dynamical and algebraic equations for s, y, c, v, η, r, rˆ, f consists of the equations (2.16),
(2.18), (3.1), (3.3) and (3.5).
We assume initial conditions for the five differential equations on an interval [0, L] as follows:
s(x, 0) = s0, η(x, 0) = η0, c(x, 0) = 0, f(x, 0) = fM , v(x, 0) = v0(x)(4.1)
where v0(·) will approximate a constant multiple of the unit impulse (“delta”) function. The question of its
smoothness is not an issue here. The precise form we used is given in equation (7.1) below.
We write the system in dimensionless variables, the length and time scales to be selected later.
Then the system of equations to solve becomes:
Y = Ke + 1− S − λ1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)
,
Z(t) = z(t) = σ1S(t) + σ(−2)Y (t)
R = 1 + V − V (x′, 0) + 1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)
,
Rˆ = (1 + λ2 + λ2V )(V (x′, 0)− V )− (1 + λ2V )
[
1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)]
,
∂S
∂t′
=
(
−k2σ1S(t) + k(−1)σ(−2)Y (t)
)
ρ0N
1 + Z
,
∂V
∂t′
= −k4λ2RV,
∂C
∂t′
= nk5(t′)RˆY − µC,
∂F
∂t′
=
4
T f
F (1− F )N − Kcatλ3CF
1 + ρfF
,
∂N
∂t′
= D
∂
∂x′
(
N
∂
∂x′
(
ln
N
T (C,F )
))
,
(4.2)
where T (C,F ) = τ(r0C, fMF ). The sensitivity constants αi,βj may be redefined so that T is independent of
the scale factors r0, fM .) The astute reader will notice that we cannot scale away n as the ratio C/n does not
appear in the fibronectin equation or in the cell movement equation. This is the critical point of this paper.
If n is large, the decay in fibronectin will be very large even if v is small. Likewise, the cell movement will
be surprisingly large in spite of the presence of only a small amount of growth factor. Boundary conditions
are needed only for the last of the above equations. The no-flux conditions:
N
∂
∂x′
(
ln
N
T (C,F )
)
x′=0
= N
∂
∂x′
(
ln
N
T (C,F )
)
x′=1
= 0(4.3)
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will suffice for our purposes.
The nondimensionalized initial conditions become:
S(x′, 0) = 1, N(x′, 0) = 1, C(x′, 0) = 0, F (x′, 0) = 1, V (x′, 0) = v0(Lx′)/r0.(4.4)
Remark 2. It may be that growth factor is being applied to the exterior of the basement lamina at a rate
of vr(x, t) micro moles per liter per hour and that the amino acid concentration in the plasma is varying at
a rate of sr(t) micro moles per liter per hour. (This assumes that the amino acids are “well mixed” while
there is a spatial distribution of growth factor.) If these are written in non dimensional variables, then with
Vr(x′, t′) = Tvr(Lx′, T t′)/r0 and Sr(t′) = Tsr(Tt′)/s0 the system 4.2 is to be replaced by
Y = Ke + 1− S − λ1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)
+
∫ t′
0
Sr(s′) ds′,
Z = σ1S + σ(−2)Y
R = 1 + V − V (x′, 0)−
∫ t′
0
Vr(x′, s′)ds′ +
1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)
,
Rˆ = (1 + λ2 + λ2V )
(
V (x′, 0) +
∫ t′
0
Vr(x′, s′)ds′ − V
)
,
− (1 + λ2V )
[
1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)]
,
∂S
∂t′
=
(
−k2σ1S(t) + k(−1)σ(−2)Y (t)
)
ρ0N
1 + Z
+ Sr(t′),
∂V
∂t′
= −k4λ2RV + Vr(x′, t′),
∂C
∂t′
= nk5(t′)RˆY − µC,
∂F
∂t′
=
4
T f
F (1− F )N − Kcatλ3CF
1 + ρfF
,
∂N
∂t′
= D
∂
∂x′
(
N
∂
∂x′
(
ln
N
T (C,F )
))
(4.5)
We insert these two source terms for two disparate reasons. In the application of this work to a coupled system
of ECM-capillary transport equations, the source term vr(x, t) will be proportional to the concentration of
VEGF molecules that have diffused across the ECM from a remote avascular tumor (See [15] for an illustration
of this). Also, a tumor cell that has moved away from a remote tumor and implanted itself just inside the
capillary wall (metastasis) can serve as a source of VEGF.
The amino acid concentration in the blood is renewed periodically during the day. The source term reflects
this renewal. Generally the total available amino acid concentration will be some periodic function of time.
Tumor secreted growth factor induces an excess production of protease by endothelial cells from the blood
amino acids that constitutes a part of the extra burden on the body’s resources. In particular, the larger n
is, the greater is this burden.
5. Instability analysis
The system (4.2) together with (4.3) and (4.4) can be viewed as a dynamical system in which we are
perturbing the rest state
Re = 〈S, Y,R, Rˆ, V, C, F,N〉 = 〈1,Ke, 1, 0, 0, 0, 1, 1〉
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by perturbing V (x′, 0) from zero. As is well known, theorems that claim stability of rest states from state-
ments of their linearized stability, are rare and, in most cases involving nonlinear partial differential equa-
tions, non-existent. However, the converse is true, namely, if the linearized problem is unstable, then so is
the nonlinear problem.
Suppose, as is the case biologically, that V (x′, 0) = δv0(x′) where  > 0 is small. Then set
〈S, Y,R, Rˆ, V, C, F,N〉 = 〈1− δs,Ke − δy, 1 + δr, δrˆ, δv, δc, 1− δf, 1 + δη〉(5.1)
where δg denotes a small perturbation in the quantity g. Using gt′ to denote partial differentiation with
respect to t′, we obtain to first order in :
δy = −δs+ λ1
n
(
δc(x′, t′) + µ
∫ t′
0
δc(x′, s′) ds′
)
,
δr = δv − δv0 + 1
n
(
δc(x′, t′) + µ
∫ t′
0
δc(x′, s′) ds′
)
δrˆ = (1 + λ2)(δv0 − δv)−
[
1
n
(
δc(x′, t′) + µ
∫ t′
0
δc(x′, s′) ds′
)]
,
(δs)t′ = [−k2σ1δs(t) + k(−1)σ(−2)δy(t)]ρ0/(1 + σ1 +Keσ(−2))
(δv)t′ = −k4λ2δv,
(δc)t′ = nk5(t′)Keδrˆ − µδc,
(δf)t′ =
−4
T f
δf +
Kcatλ3δc
1 + ρf
,
(δη)t′ = D
[
(δη)xx − ∂
∂x
(
∂CT (0, 1)(δc)x − ∂FT (0, 1)(δf)x
T (0, 1)
)]
.
(5.2)
Thus, δv converges uniformly and exponentially rapidly to zero. If we assume that, as t′ → +∞, the solution
of (5.2) converges to a steady state, then, suppressing the argument x′
lim
t′→∞
〈δs, δy, δr, δrˆ, δv, δc, δf, δη〉 = 〈δse, δye, δre, rˆe, δve, δce, δfe, δηe〉,(5.3)
δve = 0 and δye = Keδse. From the first of (5.2) we see that
δse =
λ1
n(1 +Ke)
(
δce(x) + µ
∫ ∞
0
δc(x′, s′) ds′
)
.
In order that the integral on the right converge, we must have δce(x′) = 0. Thus, for each x′,∫ ∞
0
δc(x′, s′) ds′ =
nδse(x′)
µ(Ke + 1)
.(5.4)
Since δce = 0, we must also have δrˆe = 0. Therefore
∫∞
0
δc(x′, s′) ds′ = n(1 + λ2)δv0/µ. This gives us an
indication of how much protease we can expect from the system for small concentrations of growth factor.
Setting (δf)t = 0 and using δce = 0 again, we see that δfe = 0. Consequently, δηe,xx = 0. Therefore, using
the boundary conditions we conclude that δηe ≡ 0.
Summing up, we have, together with (5.4)
δRe = 〈δse, δye, δre, δrˆe, δve, δce, δfe, δηe〉
= δv0(1 + λ2)
〈
λ1
Ke + 1
,
Keλ1
Ke + 1
,
λ2
1 + λ2
, 0, 0, 0, 0, 0
〉
.
(5.5)
(The apparent increase in available receptors is an artifact of the Michaelis-Menten assumption in (2.14).
We assumed at the outset that r0 receptors were free and r0v0/K2m were bound. When all the growth factor
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is gone from the system, the number of free receptors returns to its expected value, r0 + r0v0/K2m (or, in
this case, 1 + δre) which is the concentration of free receptors together with the concentration of receptors
which are initially bound up with the growth factor bolus.)
This means that under small perturbations, the linearized system (5.2) carries the rest state Re to a new
rest state Re + δRe and hence cannot be stable.
We illustrate this instability in the computations below.
6. Inhibition
One would like to inhibit the production of protease with some sort of inhibitor. There are, as one sees
from the mechanism described in the appendix below, several points at which inhibition would be effective.
For example, in the overall mechanism (2.5) - (2.8), one might try to inhibit protease production with a
protease inhibitor, or growth factor with a growth factor inhibitor, or try to block receptor function with a
receptor inhibitor.
The mechanism seems to suggest that it would be better to inhibit the production of Rˆ either by inacti-
vating growth factor or by interfering with any of the steps leading to the production of C rather than by
trying to inactivate C directly. (That is, if the cost of inhibiting a molecule of growth factor is the same a
inhibiting a molecule of protease, it should be much more expensive to inhibit protease than growth factor
when n is large. The situation is actually worse from this point of view since nature puts in a significant
amount of energy in the regulation of protease via inhibitors.)
In order to analyze such statements, we argue as follows:
If Iv, Ic, Ir are inhibitor molecules, consider the equilibria:
Iv + VAVI ,(6.1)
Ir +RARI .(6.2)
and
Ic + CACI .(6.3)
where the subscripts A, I refer to the active and inert forms of the molecular species to which the subscript
is attached. Let νve , ν
c
e , ν
r
e be the equilibrium constants for each of these reactions.
We begin with the case of growth factor inhibition. Thinking of the concentration of each species as
both space and time dependent, the total concentration of growth factor, vtot, in the system consists of
the concentration of active molecules (va), the concentration of inhibited molecules vi, the concentration of
molecules bound to receptors m and the concentration of molecules that have been degraded v∗a. If we assume
that the rate of supply of growth factor is vr(x, t) then we have the following dynamics and conservation
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laws:
∂va
∂t
= k(−3)m(t)− k3r(t)va(t)− va(x, t),
∂m
∂t
= k3r(t)va(t)− (k(−3) + k4)m(t),
∂r
∂t
= k5(t)rˆ(t)y(t) + k(−3)m(t)− k3r(t)va(t),
∂rˆ
∂t
= k4m(t)− k5(t)rˆ(t)y(t),
∂v∗a
∂t
= k4m(t),
∂vtot
∂t
= vr(x, t),
vtot = va + vi +m+ v∗a,
vi = νve vaiv
(6.4)
where iv is the concentration of inhibitor and where va is a sink term to be determined that describes the
effect of the inhibitor on the growth rate of active receptors. In order to determine the form of va, we take the
time derivative of the seventh equation after using the eighth equation to eliminate vi and the first equation
to eliminate ∂tva to obtain
vr = (1 + νve iv)v
s
a + vaν
v
e ∂tiv + ν
v
e iv[k(−3)m(t)− k3r(t)va(t)]
This leads us to:
∂
∂t
[va(1 + νve iv)] = k(−3)m(t)− k3r(t)va(t) + vr(x, t)
It is convenient to define v = va + vi = (1 + νve iv)va as the free growth factor, i.e. the concentration of
growth factor that is neither receptor bound nor destroyed. Then the differentiated form of the equations
which replace the last two equations in (2.13):
∂
∂t
(rˆ +m+ r) = 0
∂
∂t
(rˆ +m+ v) = −k5rˆy + vr.
(6.5)
These equations are of the same form as the differentiated form of the last two equations in (2.13) with the
exception that now we have included the source term for growth factor in the second equation. Now the
second equation in (2.14) takes the form
m(t) =
r(t)va(t)
K2m
.(6.6)
We will also need an equation which describes the time dynamics for the inhibitor:
∂iv
∂t
= ιsv(t)− µiv iv.(6.7)
where, from the point of view of the patient, the half life, ln 2/µiv , should be large. The initial condition for
(6.7) may be taken to be iv(x, 0) = i0(x). (If the inhibitor is introduced intravenously, we may take i0 = 0
and ιsv to be a constant.)
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We list here only the dimensionless form of the equations in (4.5) which must be changed to reflect the
altered dynamics:
Rˆ =
(
1 +
λ2(1 + V (x′, t′))
1 + νve Iv(x′, t′)
)(
V (x′, 0) +
∫ t′
0
Vr(x′, s′)ds′ − V (x′, t′)
)
,
−
(
1 +
λ2V (x′, t′)
1 + νve Iv(x′, t′)
)[
1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)]
,
∂V
∂t′
= −k4R λ2V1 + νve Iv(x′, t′)
+ Vr(x′, t′),
∂Iv
∂t′
= Isv(t)− µivIv.
(6.8)
(The equation for R is unchanged from that (4.5).) The source term ιsv has been replaced by its non
dimensional form Isv(t
′) ≡ Tιsv(t′)/r0, iv by Iv = iv/r0, νve = r0νve and µiv = Tµiv .
The astute reader will note that the inhibition of V is expressed by the replacement of λ2 by λ2/(1 +
νve Iv(x
′, t′)). As we let νev increase without bound, i. e. as we drive the equilibrium inhibition to the right,
this coefficient will tend to zero. This will drive R to unity and Rˆ to zero and there will tend to be very few
activated receptors to convert intracellular resources into protease.
We turn next to (6.2), the case of receptor inhibition. Here the situation is somewhat similar to the first
case. We have rtotal = ra + ri + m + rˆ = r0 + m0 as the concentration of receptors available a very short
time after the reaction has begun. (Again, each variable is potentially a function of position and time.) The
chemistry dictates the following dynamical equations and conservation laws:
∂ra
∂t
= k5(t)rˆ(t)y(t) + k(−3)m(t)− k3ra(t)v(t))− rsa,
∂m
∂t
= k3ra(t)v(t)− (k(−3) + k4)m(t),
∂v
∂t
= k(−3)m(t)− k3ra(t)v(t),
∂rˆ
∂t
= k4m(t)− k5(t)rˆ(t)y(t),
rtotal = ra + ri +m+ rˆ = r0 +m0
ri = νrerair
(6.9)
where now rsa is a sink for activated receptors. It is clear that
∂
∂t
(rˆ +m+ ra) = −rsa,
∂
∂t
(rˆ +m+ v) = −k5rˆy + vr.
(6.10)
From the first of these and the sixth of (6.9), we see that we have no choice but to take
rsa = ∂tri.
With this choice, we are once again led to:
∂
∂t
(rˆ +m+ r) = 0,
where now r = ra + ri = (1 + νre ir)ra denotes the concentration of receptors per cell at time t which are not
bound to growth factor nor part of an activated receptor complex. The second equation in (2.14) takes the
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form
m(t) =
ra(t)v(t)
K2m
.(6.11)
The altered dynamics are of the same form as given in (6.8) namely
Rˆ =
(
1 +
λ2(1 + V (x′, t′))
1 + νreIr(x′, t′)
)(
V (x′, 0) +
∫ t′
0
Vr(x′, s′)ds′ − V (x′, t′)
)
,
−
(
1 +
λ2V (x′, t′)
1 + νreIr(x′, t′)
)[
1
n
(
C(x′, t′) + µ
∫ t′
0
C(x′, s′) ds′
)]
,
∂V
∂t′
= −k4R λ2V1 + νreIr(x′, t′)
+ Vr(x′, t′),
∂Ir
∂t′
= Isr (t)− µirIr.
(6.12)
The source term ιsr has been replaced by its non dimensional form I
s
r (t
′) ≡ Tιsr(t)/r0, ir by Ir = ir/r0,
νre = r0ν
r
e and µir = Tµir as before.
Thus the dynamics of inhibition of growth factor (equations (6.8)) or the inhibition of receptor activation
(equations (6.12)) have precisely the same form. This model predicts that equal inhibitor equilibrium constants
and equal bolus concentrations or source rates of either type of inhibitor will result in equal inhibition of
fibronectin decay and aggregation of endothelial cells.
Remark 3. If one introduces both inhibitor types the resultant equations are modified to the extent that
λ2 in (4.5) is replaced by
λ2
(1 + νreIr(x′, t′))(1 + νve Iv(x′, t′))
wherever it appears. Therefore, even if the equilibria for both types of inhibition are relatively modest, i.e.,
the constants νve , νre are not inordinately large, the combined effect of two such inhibitors is greater by a factor
of one of them over the other than either either one alone. (This result is not unexpected. It is dictated by
the kinetics. If both V and R are inhibited, then the concentration of [VARA] is very nearly proportional to
the product of the concentrations of each active species by our version of the Michaelis-Menten hypothesis.)
When (6.3) is the mechanism, the situation is much easier to describe: First, the concentration of protease
is replaced by the concentration of active protease in the fibronectin and EC movement equations. Then
[C] = [CA] + [CI ] + [CAF ] = [CA] + [CI ] + [CA][F ]/Km,
[CI ] = νce [Ic][CA].
(6.13)
The total concentration of enzyme available for protease degradation is [C]− [CI ].
We see that
[CA] =
[C]
1 + νce [Ic] + [F ]/Km
(6.14)
which must be small in order to inhibit the onset of angiogenesis. This will be the case if νce is very large
and n is not too large in the case that the the inhibitor concentration is modest. Unfortunately, n is large,
and for at least one inhibitor, plasminogen derived angiostatin which is an inhibitor of tPA, the equilibrium
constant is of the order of one (µM)−1 and hence is not very large.
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Suppressing (x′, t′) and passing to dimensionless variables,
C = Ca + Ci + ρfCaF,
Ci = νceCaIc,
C˜a ≡ C − Ci.
(6.15)
the first seven equations in (4.5) are unchanged while the last two and the cell movement equation become:
∂Ic
∂t′
= −µicIc + Isc (t′),
∂F
∂t′
=
4
T f
F (1− F )N −Kcatλ3CaF,
∂N
∂t′
= D
∂
∂x′
(
N
∂
∂x′
(
ln
N
T (C˜a, F )
))
.
(6.16)
A final observation: It is straightforward to modify either (4.2) or(4.5) in the case that one has one or
more inhibitors, one which acts against growth factor, a second which acts against receptor signaling, and a
third which acts against protease.
7. The Numerical simulations
Below we present some simulations using an initial bolus of growth factor rather than a source. We take
v0(x) =
{
V0N [1− cos(2pi(x− xl)/(xr − xl))]d if xl ≤ x ≤ xr
0 if 0 ≤ x < xl or xr < x ≤ L
(7.1)
where N = N(d) is a normalizing constant chosen so that∫ xr
xl
v0(x) dx = V0.
This choice, for large d corresponds roughly to a δ-function bolus of magnitude V0. Since the amplification
factor n is not known (and is also growth factor dependent) we have taken it to be a constant, for lack of
better information at the current writing.
We used the values in Table 4 for the various parameters and constants:
In the above table, the constants K1m, K
1
cat are taken from [7]. The constants k5, t0 are based on the
estimated EC response time to growth factor [27]. The choices ψ(F ) = 4F (1− F ) and φ(c) = Ace−ξc2 were
taken in the probability transition function. (Here A is the reciprocal of the maximum value of ce−ξc
2
. )
In the actual simulations below we have reduced the constant S0 by a factor of 10x in order to illustrate
how the growth factor draws on the external resources via this transfer mechanism.
1. In the first set of simulations, illustrated by the eight panels in Figure 1, we fix the initial concentration
of growth factor.
There are two input sources which regulate the EC-fibronectin response. The first is the quantity
of growth factor in the bolus while the second is the quantity of externally supplied resources reflected
in the magnitude of S0. This is quite a large quantity, and for the levels of growth factor which are
found in tissue samples, is far more than is needed to drive the computations. Therefore, in the figures
below, we have reduced the number S0 by a factor of 105. The second regulator of EC response is the
magnitude of the growth factor bolus.
The computations illustrate the instability discussed above. As one can see from the figures, although
the growth factor decays very rapidly due to the large influx of extracellular resources, its effects are
felt after several hours in the form of a protease “bolus”. This bolus rapidly disappears although the
fibronectin and EC profiles “remember” it.
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Notice that the EC concentrations in panel 8 clearly follow the fibronectin concentrations after
100 hours (when the protease has nearly all decayed) as the theory dictates. Observe also that the
fibronectin density vanishes over an interval of approximately 6-8 microns, about the diameter of a
capillary. This opening is “lined” with EC in the sense that the EC density is highest along the edges
of the capillary opening and vanishes near the center of the capillary opening.
2. With the above bolus of growth factor, a uniform bolus of growth factor inhibitor (or, as remarked
above receptor inhibitor) of concentration of 5.0(10−4)µM is introduced in the blood stream. The
results are illustrated in the second set of eight panels. It is assumed that this inhibitor is very effective
(νe ≈ 106µM) and that it has a long half life. (We have taken this to be 100 times longer than that of
the protease.) In Figures 2A, 2B, the inhibitor bolus was introduced at the same time as the growth
factor bolus was introduced. Notice that although the channel opening does not close, it does become
more sharply defined. It is also narrower than had the inhibitor not been introduced.
The effect of the inhibitor is to delay action of the growth factor. As the inhibitor decays, the
equilibrium between the inhibited and uninhibited form of the receptor (or growth factor) shifts to the
left releasing more of the uninhibited receptor or growth factor. If the decay constant for inhibitor is
set to zero, then the system shifts to a new state in which λ2 is replaced by λ2/(1 + νeI0) where νe is
one of the two equilibrium constants and I0 is the magnitude of the inhibitor bolus.
In Figures 2C, 2D, the inhibitor bolus was introduced 50 hours after the growth factor bolus was
introduced. Notice that while the protease density is reduced considerably, the channel does not close
at those points where it was completely open (i. e. where F (x, t) = 0). Notice the attempt by the
endothelial cell density to spread out at and slightly after 50 hours. The channel opening does not
(and, in this model, cannot) narrow in this case.
If we had included a diffusion term in the fibronectin equation, then the channel opening would
close, although, since the diffusion constant for fibronectin is very small, this would not be noticeable
here [15].
3. Finally, a protease inhibitor is introduced in lieu of the other two types. Here again, it is assumed that
this inhibitor is long lived and very effective. The inhibitor bolus was introduced fifty hours after the
growth factor bolus. (Introducing the bolus at time zero just means that we will have a decayed value
of inhibitor at the time of onset of protease production. This again involves a simple rescaling of λ2 at
that time.)
8. Appendix
The process, as currently understood, by which growth factor signals endothelial cells to generate protease
may be outlined as follows,
I. A growth factor molecule binds to a cell receptor to form a receptor complex [RV ]. The receptor
complex is activated by this binding. The activated receptor modifies (phosphorylates) portions of
itself such that it is now attractive for the binding of an adapter protein that in turn binds a GDP/GTP
exchange factor. This exchange factor forms a complex with a monomeric G−protein with the resulting
G-protein-RV complex, G′.
This activated complex is then invaginated into the interior of the cell and follows one of two
pathways:
IIa. The activated G protein, G′, can break down in three steps to yield degraded growth factor and receptor
products as well as the original molecule of G−protein.
IIb. Before following IIa,the activated complex activates a series of enzymes in several steps. First it
activates Raf (MAP kinase-kinase-kinase). The activated Raf then activates Mek (MAP kinase-kinase).
Activated Mek then follows one of two paths.
IIIa. The Mek forms a non-competitive feedback loop by activating the enzyme phosphatase in the cytoplasm
which, in its turn, acts on activated Raf to return it to the inactive state.
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IIIb. The Mek goes on to interact with MAP kinase to produce activated MAP kinase.
VI. Activated MAP kinase activates transcription factor either in the cytoplasm or by first moving to the
nucleus and activating transcription factors that are resident in the nucleus.
V. The activated transcription factor activates the DNA to form an activated DNA-transcription factor
complex.
VIa. RNA polymerase is activated by this complex to synthesize messenger RNA (mRNA) encoding protease.
The mRNA is transported to the cytoplasm where the ribosome translates it to assemble the protease
from the cytoplasmic amino acids.
VIb. RNA polymerase is also activated by this complex to synthesize messenger RNA (mRNA) encoding re-
ceptor protein. This mRNA is transported to the cytoplasm where ribosome translates it to reassemble
a receptor of the original type from the cytoplasmic amino acids.
The process V Ia, will in general, be repeated several times in succession resulting in the production of several
molecules of protease being synthesized for each molecule of R that reappears on the cell surface. (That is,
in the time that a receptor is degraded, resynthesizes via V Ib and exported to the surface of the cell, several
molecules of protease will have been synthesized.)
The result of both of V Ia, b is a depletion of the cell amino acids. These cytoplasmic amino acids are
replaced by amino acids from the ECM or the blood plasma as outlined above, concurrently with the assembly
of the protease molecules.
We begin with item I in the outline above.
V +R
k1

k(−1)
RV,
RV
k2−→(RV )′
(8.1)
which summarizes the attachment and activation of the receptor R. Then the G− protein binds with this
activated complex
(RV )′ +G
k3

k−3
E,
E
k4

k−4
G′ + (RV )′
(8.2)
where G′ is the activated G−protein complex with (RV )′. During this process, (RV )′ is being invaginated
by the cell. During this process two events occur. For IIa,
(RV )′ k5−→(RV )′′,
G′ k6−→G,
(RV )′′ k7−→V ∗ +R∗
(8.3)
where V ∗, R∗ are the resultant products of V,R degradation.
For IIb,along the scaffold, G′ catalyzes K vis:
G′ +K
k9

k−9
G′K,
G′K k10−−→G′ +K ′.
(8.4)
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Then K ′ catalyzes L vis:
K ′ + L
k11

k−11
K ′L,
K ′L k12−−→L′ +K ′
(8.5)
At this point, one of two further events occur, IIIa, which is a non-competitive feedback loop:
L′ + Z
k13

k−13
L′Z,
L′Z k14−−→L′ + Z ′
(8.6)
Z ′ +K ′
k15

k−15
Z ′K ′,
Z ′K ′ k16−−→K + Z ′.
(8.7)
Or, for IIIb, L′ goes on to activate M :
L′ +M
k17

k−17
L′M,
L′M k18−−→L′ +M ′
(8.8)
which in turn activates transcription factor Tr:
Tr +M ′
k19

k−19
TrM
′,
TrM
′ k20−−→T ′r +M ′.
(8.9)
If it is not already resident in the nucleus, the transcription factor makes its way to the cell nucleus via
T ′r
kcn20−−→T ′′r(8.10)
where “cn” means “cytoplasm-nucleus”. The path again splits, this time in the nucleus, via paths VIa,b.
The activated transcription factor may activate the DNA to produce protease via
T ′′r +Dn1
k21

k−21
T ′′r Dn1,
T ′′r Dn1
k22−−→T ′′r +Dn′1.
(8.11)
Dn′1 + P
k23

k−23
Dn′1P,
Dn′1P
k24−−→Dn′1 +Rn′,
Dn′1
k′24−−→Dn1
(8.12)
where the last step indicates the return of the activated DNA to the inactive state.
The mRNA is modified and then transported to the cytoplasm via
Rn′1
k24nc−−−→Rn1.(8.13)
(This is actually a several step process, each with a rate constant, some of which happen simultaneously.)
22 HOWARD A. LEVINE & ANNA L. TUCKER & MARIT NILSEN-HAMILTON
The ribosome then translates the mRNA into protease:
Rn1 +Rb
k25

k−25
Rn1Rb,
Y +Rn′1Rb
k26−−→Rn1 +Rb+ nC ′
(8.14)
where Y denotes the concentration of the available amino acids in the cytoplasm. The factor n is included
here to represent the number of times the ribosome reads the mRNA before it is degraded via:
Rn1
k24rna−−−−→B(8.15)
into the bases and sugars of which it is comprised. The other part of the path,VIb, reproduces the cell
receptor:
T ′′r +Dn2
k27

k−27
T ′′r Dn2,
T ′′r Dn2
k28−−→T ′′r +Dn′2.
(8.16)
Dn′2 + P
k29

k−29
Dn′2P,
Dn′2P
k30−−→Dn′2 +Rn′2,
Dn′2
k′30−−→Dn2
(8.17)
where again the last step indicates the return of the activated DNA to the inactive state. The mRNA is
modified and then transported back to the cytoplasm via
Rn′2
k30nc−−−→Rn2.(8.18)
Rn2 +Rb
k31

k−31
Rn2Rb,
Y +Rn2Rb
k32−−→Rn2 +Rb+R′.
(8.19)
where Y denotes the concentration of the available amino acids in the cytoplasm. It is assumed here that
the ribosome reads the mRNA just once before it is degraded via:
Rn2
k30rna−−−−→B(8.20)
into the bases and sugars of which it is comprised.
The protease C ′ is moved to the cell exterior by a transfer mechanism that involves lipid channels and
lipid vesicles:
Pt + C ′
k33

k−33
PtC
′,
PtC
′ k34−−→Pt + C.
(8.21)
The receptor protein R′ moves to the lipid bilayer via
R′ k35−−→R.(8.22)
In addition to these we also need to write down mechanisms by which the proteases and receptors are
transfered back to the extracellular matrix. In so far as the actual protein translation steps are concerned,
(8.14), (8.15), (8.19), (8.20) are only gross simplifications of these complicated events.
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Clearly an attempt to write down the kinetic equations for the system of reactions (8.1)-(8.22) without
some assurance of the availability of the kinetic constants for these equations and some assurance that the
rate determining steps are all included in the above sequence would be folly. On the other hand, there is
some educational value in recording the chemical equations and the pathways. Such a long chain of chemical
events certainly demands some realistic simplification such as described above.
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1. Figure 1A. Extra- and intracellular resource, receptor and activated receptor time courses without
inhibitor.
2. Figure 1B. Growth factor, protease, fibronectin and endothelial cell time courses without inhibitors.
3. Figure 2A. Extra- and intracellular resources, receptor and activated receptor time courses with growth
factor or receptor inhibitor (tv = 0.0).
4. Figure 2B. Growth factor, protease, fibronectin and endothelial cell time courses with growth factor or
receptor inhibitor (tv = 0.0).
5. Figure 2C. Extra- and intracellular resources, receptor and activated receptor time courses with growth
factor or receptor inhibitor (tv = 50.0).
6. Figure 2D. Growth factor, protease, fibronectin and endothelial cell time courses with growth factor
or receptor inhibitor (tv = 50.0).
7. Figure 3A.Extra- and intracellular resources, receptor and activated receptor time courses with protease
inhibitor (tc = 50.0).
8. Figure 3B. Growth factor, protease, fibronectin and endothelial cell time courses with protease inhibitor
(tc = 50.0).
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Table 1. Notation
species notation concentration source/location
amino acids X [X] = s(t) tissue and plasma
transport protein Pt [Pt] = p(t) trans-membrane
amino acid - transport protein complex XPt [XPt] = `(t) cell cytoplasm
amino acids Y [Y ] = y(t) cell cytoplasm
vascular endothelial growth factor V [V ] = v(t) extracellular matrix
receptor-VEGF complex RV [RV ] = m(t) cell surface and lipid bilayer
invaginated and degraded VEGF V ∗ [V ∗] = v∗(t) cell cytoplasm
G-protein activated [RV ] complex Rˆ [Rˆ] = rˆ(t) cytoplasm
surface receptor R [R] = r(t) trans-membrane
total available extracellular protease C [C] = c(t) extracellular matrix
basement lamina protein F [F ] = f(t) basement lamina
Table 2. Simulation Parameters
variable name units dimensioned variable dimensionless variable
position microns 10−6m x x′ = x/L
time hours t t′ = t/T
growth factor concentration micro-moles/liter µM v(x, t) V (x′, t′) = v(x, t)/r0
receptor density µM r(x, t) R(x′, t′) = r(x, t)/r0
receptor-VEGF complex µM rˆ(x, t) Rˆ(x′, t′) = rˆ(x, t)/r0
extracellular protease µM c(x, t) C(x′, t′) = c(x, t)/r0
extracellular resources µM s(x, t) S(x′, t′) = s(x, t)/s0
intracellular resources µM y(x, t) Y (x′, t′) = y(x, t)/s0
basement lamina protein µM f(x, t) F (x′, t′) = f(x, t)/fM
endothelial cell (EC) density cells/liter η(x, t) N(x′, t′) = η(x, t)/η0
inhibitor concentrations (j = v, r, c) µM ij(x, t) Ij(x′, t′) = ij(x, t)/r0
inhibitor source rates (j = v, r, c) µMh−1 isj(x, t) I
s
j (x
′, t′) = ij(x, t)T/r0
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Table 3. Dimensionless parameters
initial growth factor V (x′, 0) = v(x, 0)/r0
dimensionless cell movement (diffusivity) constant D = TD/L2
dimensionless protein decay rates µj = µjT
where µj is one of µ, µiv , µir , µic
dimensionless inhibitor equilibrium constants νje = r0νje
where νje is one of ν
iv
e , ν
ir
e , ν
ic
e
dimensionless kinetic constants ki ki = kiT
where ki is one of k, k(−2)k2, k4
dimensionless kinetic function k5(t) k5(t′) = Ts0k5(t)
dimensionless delay time t′0 t
′
0 = t0/T
first renormalized initial receptor density λ1 = r0/s0
second renormalized initial receptor density λ2 = r0/K2m
third renormalized initial receptor density λ3 = r0/Km
normalized initial amino acid density σ1 = s0/K1m
normalized initial amino acid density σ(−2) = s0/K
(−2)
m
normalized initial transport protein density ρ0 = δ0η0/s0)
normalized maximum “fibronectin” density ρf = fM/Km
dimensionless“fibronectin” time T f = Tf/T
dimensionless Kcat Kcat = TKcat
Table 4. Parameter values
Literature
Km = 0.7813µM Kcat = 1.484(10)h−1 See [5].
K1m = 2.93(10
−3)µM k2 = K1cat = 9.42(10
−8h−1 See [7].
K2m = 1.4286(10
2)µM k4 = 1.04286(104)h−1 See [8].
κ = 0.6667(10−1)h−1 t0 = 1.5(10)h See notes below.
r0 = 1.0µM s0 = 2.442(103)µM See [25, 29] for r0, [4] for s0.
p0 = 1.0µM µ = 4.56h−1 Assumed that p0 ≈ r0. See [1] for µ.
µr = 0.01 ∗ µ µv = 0.01 ∗ µ Simulated value.
µc = 0.01 ∗ µ Simulated value.
νre = 5.0(10
6)µM νve = 5.0(10
6)µM Simulated value.
νce = 5.0(10
6)µM Simulated value.
iv(x, 0) = 5.0(10−4)µM ir(x, 0) = 5.0(10−4)µM Simulated value.
ic(x, 0) = 5.0(10−4)µM Simulated value.
isr(x, t) = 0.0 i
s
v(x, t) = 0.0
isc(x, t) = 0.0
T = 1.0h Tf = 1.8(10)h Time scale. See [16, 33] for Tf .
D = 3.6(10−5)mm2h−1 L = 100µ = 0.1cm See [22] for D. Length scale.
xl = 0.0 xr = 100µ
fM = 1.0(10−2)µM See [26] for fM . See notes for CM
α1 = 1.0(10−3) β1 = 1.0(10−3) Simulated value.
γ1 = 1.2 γ2 = 1.2 Simulated value.
n = 2(103) d = 30 Simulated value.
V0 = 2.5(10−4)µM Simulated value.
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Table 5. Nomenclature for reaction mechanisms
species notation source/location
growth factor V extracellular matrix
cell receptor R trans-membrane
amino acids Y cytoplasm
sugars/bases in mRNA B cytoplasm
degraded VEGF residues V ∗ cytoplasm
degraded receptor residues R∗ cytoplasm
growth factor receptor complex RV trans-membrane
activated growth factor receptor complex (RV )′ trans-membrane
G−protein G cell cytoplasm
activated G−protein G′ cell cytoplasm
activated intermediate complex G′(RV )′ cell cytoplasm
Raf K cytoplasm scaffold
activated Raf K ′ cytoplasm scaffold
Mek L cytoplasm scaffold
activated Mek L′ cytoplasm scaffold
phosphatase Z cytoplasm
activated phosphatase Z ′ cytoplasm
MAP kinase M cytoplasm scaffold
activated MAP kinase M ′ cytoplasm scaffold
transcription factor Tr cytoplasm
activated transcription factor T ′r cytoplasm
activated transcription factor T ′′r nucleus
DNA Dn1 nucleus
activated DNA Dn′1 nucleus
ribosome Rb cytoplasm
DNA Dn2 nucleus
activated DNA Dn′2 nucleus
messenger RNA Rn1, Rn2 cytoplasm
messenger RNA Rn′1, Rn
′
2 nucleus
RNA polymerase P nucleus
protease C ′ cytoplasm
protease C extra cellular matrix
“nascent” cell receptor R′ cytoplasm View publication stats
